Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.460
-0.010 (-0.68%)
At close: Nov 20, 2024, 4:00 PM
1.470
+0.010 (0.68%)
After-hours: Nov 20, 2024, 7:59 PM EST
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $18.75 million as of November 21, 2024.
Market Cap
18.75M
Enterprise Value
15.67M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $18.75M, a decrease of -43.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 18.75M | -43.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cyclo Therapeutics | 19.54M |
| Concord Medical Services Holdings | 19.54M |
| Bullfrog AI | 19.43M |
| American Shared Hospital Services | 19.08M |
| MEI Pharma | 19.06M |
| Akari Therapeutics, | 18.77M |
| Palatin Technologies | 18.18M |
| ProPhase Labs | 18.14M |